Filing Details
- Accession Number:
- 0001225208-11-012698
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-02 14:50:28
- Reporting Period:
- 2011-04-29
- Filing Date:
- 2011-05-02
- Accepted Time:
- 2011-05-02 14:50:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 901219 | Human Genome Sciences Inc | HGSI | Biological Products, (No Disgnostic Substances) (2836) | 223178468 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1346164 | Curran Simpson | 14200 Shady Grove Road Rockville MD 20850 | Sr. Vp, Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-04-29 | 26,861 | $12.38 | 72,651 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-29 | 1,154 | $9.78 | 73,805 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-04-29 | 28,015 | $28.99 | 45,790 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2011-04-29 | 1,154 | $0.00 | 1,154 | $9.78 |
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2011-04-29 | 26,861 | $0.00 | 26,861 | $12.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1 | 2013-04-22 | No | 4 | M | Direct | |
| 3,139 | 2013-12-10 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person and Charles Schwab effective March 18, 2011.
- This transaction was executed in multiple trades at prices ranging from $28.7430 to $29.32. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or the security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
- These options have fully vested and are exercisable.
Billionaire Hedge Funds
